https://www.selleckchem.com/products/OSI-906.html
NEDA represents a very important option in the treatment of PD. Criticisms on their use can be overcome through a better knowledge of these molecules and of the risk factors for adverse events which allow specialists to prevent the occurrence of undesired complications and consent a tailor-based approach. Abbreviations PD Parkinson's disease, DA dopamine agonists, NEDA non-ergot dopamine agonists, ICD impulse control disorders, DAWS dopamine agonist withdrawal syndrome, CYP Cytochrome P, PK pharmacokinetic, AUC area under the curve, HRT